搜索临床试验以:TACROLIMUS
总计1229个结果
-
Wyeth is now a wholly owned subsidiary of Pfizer完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的淋巴瘤 | 骨髓增生异常综合征 | 白血病 | 慢性骨髓增生性疾病 | 多发性骨髓瘤和浆细胞肿瘤 | 骨髓增生异常/骨髓增生性疾病 | 移植物抗宿主病美国
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Wyeth is now a wholly owned subsidiary of Pfizer终止
-
Vertex Pharmaceuticals IncorporatedTibotec Pharmaceutical Limited完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Centre Hospitalier Universitaire de Saint Etienne完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)完全的淋巴瘤 | 骨髓增生异常综合征 | 白血病 | 慢性骨髓增生性疾病 | 多发性骨髓瘤和浆细胞肿瘤 | 骨髓增生异常/骨髓增生性疾病 | 移植物抗宿主病美国
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)完全的
-
University of AarhusAstellas Pharma Inc; The Danish Kidney Association; Danish Society of Nephrology完全的
-
Temple UniversityWyeth is now a wholly owned subsidiary of Pfizer未知
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.完全的
-
Hospital Clinic of BarcelonaAstellas Pharma Inc; Fresenius AG终止
-
University Hospital, BonnOctapharma; Astellas Pharma GmbH未知
-
University of California, San Francisco完全的多发性骨髓瘤 | 非霍奇金淋巴瘤 | 慢性粒细胞白血病 | 急性淋巴细胞白血病 | 急性髓性白血病 | 骨髓增生异常 | 重度再生障碍性贫血 | 淋巴增生性疾病 | Advanced Myeloproliferative Disease美国
-
Sun Yat-sen University完全的
-
Odense University HospitalLEO Pharma; University of Southern Denmark未知
-
Astellas Pharma IncAstellas Pharma US, Inc.完全的
-
Astellas Pharma IncAstellas Pharma Europe B.V.完全的
-
Astellas Pharma IncAstellas Pharma Europe B.V.完全的
-
Astellas Pharma Inc完全的
-
University Medicine Greifswald完全的
-
KU LeuvenFund for Scientific Research, Flanders, Belgium完全的
-
Colorado Blood Cancer Institute未知
-
Wyeth is now a wholly owned subsidiary of Pfizer完全的移植物排斥 | 肾功能衰竭 | 肾移植
-
Seoul National University Hospital未知